Showing results (121-130 of 301) with videos related to
Sort By:
Pageof 31
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2015
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activationNathalie Knies, Begüm Alankus, Andre Weilemann, et al.Journal of Extracellular Vesicles|March 7, 2024
PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancerNadja Schöne, Marcel Kemper, Kerstin Menck, et al.British Journal of Pharmacology|June 25, 2026
Pharmacological activation of NO-cGMP signalling attenuates metabolic dysfunction-associated steatohepatitisKrithika Rajeeth, Malte Roessing, Moritz Lehners, et al.Annals of Hematology|February 7, 2023
Amsacrine-based induction therapy in AML patients with cardiac comorbidities: a retrospective single-center analysisDavid Kuron, Alexander Pohlmann, Linus Angenendt, et al.Oncotarget|September 22, 2021
Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibitionMarcel Kemper, Georg Evers, Arik Bernard Schulze, et al.Annals of Hematology|June 20, 2024
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOPBoris Kubuschok, Burkhard Otremba, Manfred Welslau, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2007
Bcl10 controls TCR- and FcgammaR-induced actin polymerizationDaniel Rueda, Olivier Gaide, Liza Ho, et al.International Journal of Cancer|September 23, 2014
Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κBAnne Flörcken, Michael Grau, Annette Wolf, et al.Hematological Oncology|March 15, 2026
Role of Radiotherapy in the Era of Novel Immune-Based Treatment Strategies for Multiple MyelomaTom Schlusemann, Evgenii Shumilov, Gabriele Reinartz, et al.British Journal of Haematology|June 26, 2026
Response-adapted consolidation and salvage strategies in secondary central nervous system lymphoma: Insights from a multicentre cohortFarina Eigendorff, Fabian Görke, Vanja Zeremski, et al.Pageof 31